Delivery Order SPE2DB20D1051-SPE2DB24FD9DE
Award Date
8/30/24
Potential Completion Date
9/3/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Lamotrigine ER 250 mg tablets. The contract, valued at $2,235.55, has a period of performance through March 11, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,146.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Lamotrigine ER 50 mg tablets, a neurological medication. The contract has a firm fixed-price pricing type and an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,043.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4567998899 LAMOTRIGINE ER 200 MG TABLET 30S, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award is for the supply of the medication Lamotrigine ER 250 mg tablets to the Defense Logistics Agency (DLA). The $4,284.45 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 9, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 4,567,745,478 units of the drug Lamotrigine ER 300 mg tablets. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 31, 2025. The contract has a ceiling value of $4,041.17 and runs through April 1, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $1,995.26, is for the supply of Lamotrigine ER 250 mg tablets. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp to provide Lamotrigine ER 50 mg tablets. The award is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to support military healthcare programs and facilities worldwide....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,428.90 firm fixed-price delivery order contract is for the supply of 4567983871 - Lamotrigine ER 300 mg Tablets. The contract has an ultimate completion date of April 22, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,893.38 firm-fixed-price delivery order is for the supply of 4565353577 - Lamotrigine Extended-Release 300 mg Tablets in 30-count packages. The award has an ultimate completion date of August 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies...
This is a $1,065.82 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of 200 mg Lamotrigine ER tablets, which are used to treat certain types of seizures. The contract has a completion date of June 24, 2025 and is not set aside for any small business category. AmerisourceBergen Drug Corp is the prime...